Oral Anti-Diabetic Drug Market Expands As Healthcare Providers Focus On Early Intervention And Prevention Market Trends & Business Updates
The global Oral Anti-Diabetic Drug market is poised for substantial growth, driven by increasing diabetes cases, advancements ...
Yahoo Finance2d
CORRECTING and REPLACING Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity
Over the past six months, Altasciences has completed nonclinical work for MET-233i, an ultra-long-acting injectable amylin ...
The “Holiday Pause” For GLP-1s Is Quickly Approaching — but Is It Safe?
Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...
KSTP-TV3d
Inside Your Health: GLP-1 medications
A new study published in the journal Jama estimated that more than 137 million American adults are eligible for medications ...
Supplements claiming to work like Ozempic and Wegovy are now being sold – here’s what the evidence actually says about these products
Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.
Daily3d
No significant benefit of IV exenatide in reducing complications during cardiac surgery, finds GLORIOUS trial
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
Lexaria Bioscience’s Promising Outlook on GLP-1 Drugs
Lexaria Bioscience (LEXX) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now ...
MedPage Today4d
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome
The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...
biopharma-reporter4d
Biohaven’s myostatin inhibitor fails in phase 3 spinal muscular atrophy trial
Despite disappointing results in the genetic neurodegenerative disorder, the drug shows potential for treating obesity.
Weight-loss drugmakers' stocks get a boost from new Biden proposal on drug coverage, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were mostly higher early Tuesday after the Biden administration proposed a rule that would allow Medicare ...
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...